用梅波利祖马布治疗的严重乙酸性喘患者的非常长期数据:一个病例系列
Carlo Lombardi1, Francesco Menzella2, Alvise Berti3,4
1Departmental Unit of Allergology & Respiratory Diseases, Fondazione Poliambulanza, Brescia, Italy.
Drugs in context
|July 29, 2024
概括
长期使用梅波利祖马布治疗显著降低了恶化,并允许在严重的eosinophilic喘患者的口服皮质类固醇 (OCS) 撤销. 这种生物疗法在长时间的随访期间表现出持续的疗效和耐受性.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的酸性喘往往需要长期使用口服皮质类固醇 (OCS),并与频繁的恶化有关.
- 梅波利祖马布是一种针对严重异酸性喘管理而研究的抗列素-5单克隆抗体.
研究的目的:
- 为了评估对严重异酸性喘时的梅波利祖马布治疗的非常长期数据.
- 评估喘控制,肺功能,吸入性皮质类固醇 (ICS) 剂量减少以及临床/生物参数.
主要方法:
- 追溯分析四名患有严重乙酸性喘的成年患者,他们接受了至少60个月的梅波利祖马布 (100毫克/4周) 治疗.
- 收集的数据包括ICS/OCS剂量,肺功能,乙氨基酸细胞数量,部分呼出的氧化 (FeNO),喘控制测试 (ACT) 评分和恶化率.
主要成果:
- 随访时间中位数为73.5个月,经过平均13个月的梅波利祖马布治疗,获得了OCS戒断.
- 在ACT得分,FeNO和肺功能参数中观察到显著改善.
- 观察到恶化症的显著减少,从治疗前平均每年4次减少到治疗后0次 (p=0.0286).
结论:
- 梅波利祖马布显示出作为一种"疾病修饰"剂的潜力,用于严重的酸性喘.
- 该药物具有很高的耐受性和有利的长期疗效概况,可使OCS停用并减少恶化.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
379
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
379
01:24Antiasthma Drugs: Methylxanthines
214
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
214
01:17Drugs Used in Lower Respiratory Disorders: Overview
386
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
386
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K